Cargando…
'VEEP' in children with Hodgkin's disease--a regimen to decrease late sequelae.
In an attempt to decrease the risk of second malignancies and future infertility in children with Hodgkin's disease (HD) while retaining acceptable remission rates, an anthracycline based regimen containing no alkylating agent has been devised. VEEP contains vincristine, epirubicin, etoposide a...
Autores principales: | O'Brien, M. E., Pinkerton, C. R., Kingston, J., Mott, M., Tait, D., Meller, S., Radford, M., Malpas, J., McElwain, T. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977393/ https://www.ncbi.nlm.nih.gov/pubmed/1586603 |
Ejemplares similares
-
Outcome of children with resistant and relapsed Hodgkin's disease.
por: James, N. D., et al.
Publicado: (1992) -
Rapid VAC high dose melphalan regimen, a novel chemotherapy approach in childhood soft tissue sarcomas.
por: Pinkerton, C. R., et al.
Publicado: (1991) -
'JEB'--a carboplatin based regimen for malignant germ cell tumours in children.
por: Pinkerton, C. R., et al.
Publicado: (1990) -
Childhood rhabdomyosarcoma: experience of the Children's Solid Tumour Group.
por: Kingston, J. E., et al.
Publicado: (1983) -
Hodgkin's Disease in Children
por: Smith, I. E., et al.
Publicado: (1977)